NFAT3 Protein — Nuclear Factor of Activated T-cells 3
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">NFAT3 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Nuclear Factor of Activated T-cells 3</td></tr>
<tr><td><strong>Gene</strong></td><td>[NFAT3](/genes/nfat3)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q12968](https://www.uniprot.org/uniprot/Q12968)</td></tr>
<tr><td><strong>PDB ID</strong></td><td>1p4h</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>79 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm (inactive), Nucleus (active)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>NFAT transcription factor family</td></tr>
<tr><td><strong>Aliases</strong></td><td>NFATc4, NFAT4</td></tr>
<tr><td><strong>Brain Expression</strong></td><td>[Hippocampus](/brain-regions/hippocampus), cerebral [cortex](/brain-regions/cortex), basal ganglia</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
NFAT3 (Nuclear Factor of Activated T-cells 3, also known as NFATc4 or NFAT4) is a calcium-dependent transcription factor belonging to the NFAT family. Unlike other NFAT isoforms that are widely expressed, NFAT3 exhibits more tissue-restricted expression with significant levels in the brain, cardiovascular system, and adipose tissue [@nfat2001]. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
Structure
NFAT3 is the smallest NFAT family member and contains several distinct domains:
- N-terminal transactivation domain (TAD): Proline-rich region at the amino terminus that mediates transcriptional activation
- Rel-homology region (RHR): The central DNA-binding domain that recognizes the consensus NFAT binding site (T/GGAAATCA)
- Regulatory domain: Located at the C-terminus, this region contains the calcium-responsive element that controls nuclear-cytoplasmic shuttling
- Serine-rich regions: Multiple serine residues that are phosphorylated in the cytoplasm, maintaining NFAT3 in an inactive state
The protein forms homodimers and heterodimers with other NFAT family members to bind DNA and regulate gene expression [@structure2000].
Normal Function in the Nervous System
NFAT3 plays several important roles in normal brain function:
Synaptic Plasticity and Learning
NFAT3, along with other NFAT isoforms, regulates genes involved in synaptic plasticity including:
- Synaptic vesicle proteins
- Ion channels (particularly potassium channels)
- NMDA and AMPA receptor subunits
- Postsynaptic density proteins
Neuronal Development
During neural development, NFAT3 participates in:
- Neuronal differentiation from progenitor cells
- Axon guidance and dendrite formation
- Synapse formation and maturation
Calcium Signaling
As a calcium-dependent transcription factor, NFAT3 transduces calcium signals into gene expression changes:
- Activated by calcium influx through voltage-gated calcium channels and NMDA receptors
- Dephosphorylation by calcineurin triggers nuclear translocation
- Phosphorylation by kinases (GSK3β, CK1) promotes nuclear export
Glial Cell Function
NFAT3 also functions in glial cells:
- Regulates inflammatory gene expression in [microglia](/cell-types/microglia-neuroinflammation)
- Controls astrocyte reactivity and scar formation
- Modulates oligodendrocyte differentiation [@nfat2005]
Role in Neurodegenerative Diseases
Alzheimer's Disease
NFAT3 (NFATc4) is implicated in several aspects of Alzheimer's disease pathology:
Amyloid-β Toxicity: Research demonstrates that amyloid-β peptide exposure leads to aberrant NFAT3 activation in [neurons](/entities/neurons). This activation contributes to:
- Dysregulation of calcium homeostasis
- Pro-inflammatory gene expression
- Synaptic dysfunction and dendritic spine loss
[Tau](/proteins/tau) Pathology: NFAT3 activation has been observed in tau-overexpressing neurons, where it may contribute to:
- Transcriptional alterations affecting neuronal survival
- Dysregulation of protein quality control pathways
Therapeutic Implications: The calcineurin-NFAT pathway represents a potential therapeutic target. Studies using calcineurin inhibitors have shown neuroprotective effects in AD models, partially through modulation of NFAT3 activity [@calcineurinnfat2020].
Parkinson's Disease
In dopaminergic neurons, NFAT3 participates in:
Mitochondrial Dysfunction: NFAT3 regulates genes involved in mitochondrial biogenesis and quality control. Its dysregulation may exacerbate mitochondrial dysfunction in dopaminergic neurons.
Neuroinflammation: Microglial NFAT3 activation promotes expression of pro-inflammatory cytokines including:
[α-Synuclein](/proteins/alpha-synuclein) Pathology: Evidence suggests cross-talk between NFAT signaling and α-synuclein aggregation pathways [@nfat2018].
Other Neurodegenerative Conditions
Huntington's Disease: NFAT3 activation has been reported in striatal neurons expressing mutant [huntingtin](/proteins/huntingtin), where it contributes to transcriptional dysregulation.
Amyotrophic Lateral Sclerosis (ALS): Altered NFAT3 expression has been observed in spinal cord motor neurons in ALS models.
Multiple Sclerosis: In demyelinating conditions, NFAT3 regulates immune responses that affect oligodendrocyte survival.
Protein Interactions
NFAT3 interacts with several key proteins:
| Protein | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| Calcineurin | Direct binding | Dephosphorylation, activation |
| GSK3β | Phosphorylation | Nuclear export |
| CK1 | Phosphorylation | Nuclear export |
| cAMP Response Element Binding Protein (CREB) | Co-activation | Synaptic gene expression |
| p53 | Cross-talk | [Apoptosis](/entities/apoptosis) regulation |
| [NF-κB](/entities/nf-kb) | Co-operative binding | Inflammatory gene expression |
| Class I HDACs | Repressor complex | Transcriptional repression |
Therapeutic Implications
Drug Target Potential
The NFAT3 pathway offers several therapeutic opportunities:
Calcineurin Modulation: While immunosuppressants like cyclosporine A and FK506 inhibit calcineurin, their neuroprotective effects are complex due to pleiotropic actions.
NFAT-Selective Modulators: Developing compounds that selectively target NFAT3 without affecting immune function remains a challenge but would offer more specific therapy.
Kinase Inhibitors: GSK3β inhibitors (such as lithium) indirectly modulate NFAT3 activity and have been explored in AD therapy.Biomarker Potential
NFAT3 activation status in peripheral blood mononuclear cells (PBMCs) has been explored as a biomarker for:
- Disease progression in Parkinson's disease
- Treatment response to anti-inflammatory therapies
Animal Models
Mouse models lacking NFAT3 show:
- Viable with no major developmental defects
- Impaired cardiac hypertrophy response
- Altered neuronal excitability
- Deficits in certain forms of learning
Transgenic models overexpressing NFAT3 in neurons exhibit:
- Altered synaptic plasticity
- Enhanced inflammatory responses to injury
- Variable effects on neurodegeneration models [@nfat2022]
Summary
NFAT3 is a calcium-dependent transcription factor with important roles in the nervous system. Its dysregulation contributes to the pathogenesis of multiple neurodegenerative diseases through effects on synaptic function, inflammation, and neuronal survival. While targeting the calcineurin-NFAT pathway shows therapeutic promise, selective modulation of NFAT3 remains challenging. Further research is needed to clarify its precise roles in neurodegeneration and develop targeted interventions.
See Also
- [NFAT3 Gene](/genes/nfat3)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Calcineurin Protein](/proteins/calcineurin-protein)
- [Calcium Signaling Pathway](/mechanisms/calcium-signaling-pathway)
References
[NFAT transcription factors: from central nervous system development to neuronal function (Graef et al., 2001) (2001)](https://doi.org/10.1016/S0896-6273(01)
[Structure and function of the NFAT family and NFAT4 (Okamura et al., 2000) (2000)](https://doi.org/10.1016/S0092-8674(00)
[NFAT4 deficiency impairs neuronal development and function (Liu et al., 2005) (2005)](https://doi.org/10.1111/j.1460-9568.2005.04016.x)
[Calcineurin-NFAT signaling in neurodegenerative diseases (Sullivan et al., 2020) (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.03.015)
[NFAT activation in dopaminergic neuron death (Liu et al., 2018) (2018)](https://doi.org/10.1002/mds.27390)
[NFAT3 in neuronal apoptosis and neurological disorders (Wang et al., 2022) (2022)](https://doi.org/10.3389/fnmol.2022.895432)